Spotlight
Henry Schein Names Frederick M. Lowery as Chief Executive Officer
Henry Schein has announced the appointment of Frederick M. Lowery as its new Chief Executive Officer, effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition.
"I am honored to join Henry Schein at such a pivotal moment. This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership," said Mr. Lowery. "I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation."
Most recently, Mr. Lowery served as Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific, leading the Fisher Scientific distribution channel's above-market performance.
"I am very pleased to welcome Fred to Henry Schein. Beyond his extensive operational experience, he brings a leadership philosophy that reflects the values that have long defined our Company," said Mr. Bergman. "Fred understands the critical role we play in supporting dental and medical practitioners, and he is exceptionally well equipped to lead Henry Schein into its next phase of growth."
Click here to read the full press release and learn more about Mr. Lowery and his more than two decades of healthcare expertise.